I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
WideMoat Capital is a consulting firm in Guadalajara, Mexico focused on supporting small and medium-sized companies with their capital raising needs, finding strategic partners, developing and improving their business models, and evaluating investment opportunities.
I'm a private investor looking for investment ideas for my personal retirement that will hopefully arrive in 2030. After hiring advisers and just barely breaking even for many years, I started taking control of my own investing in 2005. I started out learning from the Motley Fool Stock Advisor and Hidden Gems services. I learned a lot about basic investing, but found the recommendations very hit or miss. I fared pretty well during the great recession of 2008/2009 and had the fortitude to be a buyer instead of a seller. My portfolio recovered well, but as my portfolio grew I began to dread the earnings announcements of my high growth companies and their volatility. I started seeking an alternative way to invest and found Seeking Alpha and David Van Knapp, whose articles just made sense to me. Since 2010 have been focused on building a widely diversified dividend growth portfolio.
I am President and sole owner of a small corporation that performs Process Control/SCADA IT related consulting for the Oil and Gas industry. I also own a small number of rental properties.
Awarded a 2015 "Top 50 Financial Blogger" by TipRanks.com
- Ranked #44 out of 4,408 bloggers (#106 out of 8,174 overall experts) as of 8/18/15
- Follow my ongoing coverage on TerraVia (TVIA): http://seekingalpha.com/articles?filters=tvia,kevin-quon